Evidence map›Paper›PMID 31959169›Full record

Trial reportRespiratory research2020

"Can do, don't do" are not the lazy ones: a longitudinal study on physical functioning in patients with COPD.

Noriane A Sievi, Thomas Brack, Martin H Brutsche, Martin Frey, Sarosh Irani, Jörg D Leuppi, Robert Thurnheer, Malcolm Kohler, Christian F Clarenbach

Registry-linked trialAbstract readClinical Trial
In one paragraph

Trial report in Respiratory research, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT01527773 (The Obstructive Pulmonary Disease Outcomes Cohort of Switzerland), which is not on this map. Cited by 10 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT01527773 completednot on this map

The Obstructive Pulmonary Disease Outcomes Cohort of Switzerland (TOP DOCS): Phenotypes and Vascular Damage in COPD

TypeobservationalSponsorUniversity of ZurichRan2011 to 2017Enrolled313ConditionsChronic Obstructive Pulmonary Disease
3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

9 authors.

Noriane A SieviPulmonary Division, University Hospital Zurich, Raemistrasse 100, 8091, Zurich, Switzerland.ORCID http://orcid.org/0000-0003-1758-4586
Thomas BrackPulmonary Division, Cantonal Hospital of Glarus, Glarus, Switzerland.
Martin H BrutschePulmonary Division, Cantonal Hospital of St. Gallen, St. Gallen, Switzerland.
Martin FreyPulmonary Division, Clinic Barmelweid, Erlinsbach, Switzerland.
Sarosh IraniPulmonary Division, Cantonal Hospital of Aarau, Aarau, Switzerland.
Jörg D LeuppiUniversity Department of Medicine, Cantonal Hospital Baselland and University of Basel, Basel, Switzerland.
Robert ThurnheerPulmonary Division, Cantonal Hospital of Münsterlingen, Münsterlingen, Switzerland.
Malcolm KohlerPulmonary Division, University Hospital Zurich, Raemistrasse 100, 8091, Zurich, Switzerland.
Christian F ClarenbachPulmonary Division, University Hospital Zurich, Raemistrasse 100, 8091, Zurich, Switzerland. christian.clarenbach@usz.ch.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

BACKGROUND AND

objectiveReduced physical capacity (PC) and physical activity (PA) are common in COPD patients and associated with poor outcome. However, they represent different aspects of physical functioning and interventions do not affect them in the same manner. To address this, a new PC-PA quadrant concept was recently generated to identify clinical characteristics of sub-groups of physical functioning. The objective of this study was to I) proof the new concept and to verify their differentiating clinical characteristics, II) evaluate the consistency of the concept over time, III) assess whether patients changed their quadrant affiliation over time, IV) and to test if changes in quadrant affiliations are associated with changes in clinical characteristics.

methodsIn a longitudinal, prospective, non-interventional cohort with mild to very severe COPD patients, PC and PA as well as respiratory variables, COPD-specific health status, comorbidities, survival, and exacerbations were yearly assessed.

resultsData from 283 patients were analysed at baseline. Mean (min/max) follow-up time was 2.4 (0.5/6.8) years. The PC-PA quadrants could be characterized as follows: I) "can't do, don't do": most severe and symptomatic, several comorbidities II) "can do, don't do": severe but less symptomatic, several comorbidities III) "can't do, do do": few patients, severe and symptomatic, less comorbidities IV) "can do, do do": mildest and less symptomatic, less comorbidities, lowest exacerbation frequency. Of the 172 patients with at least one follow-up, 58% patients never changed their quadrant affiliation, while 17% declined either PC, PA or both, 11% improved their PC, PA or both, and 14% showed improvement and decline in PC, PA or both during study period. None of the clinical characteristics or their annual changes showed consistent significant and relevant differences between all individual sub-groups.

conclusionOur findings suggest that there are no clinical characteristics allowing to distinguish between the PC-PA quadrants and the concept seems not able to illustrate disease process. However, the already low PA but preserved PC in the "can do, don't do" quadrant raises the question if regularly assessment of PA in clinical practice would be more sensitive to detect progressive deterioration of COPD compared to the commonly used PC. CLINICAL

trial registrationwww.ClinicalTrials.gov, NCT01527773.

Indexed as

Attitude to HealthAgedBlood Gas AnalysisCohort StudiesExerciseFemaleFollow-Up StudiesHumansLongitudinal StudiesLung Volume MeasurementsMaleMiddle AgedProspective StudiesPulmonary Disease, Chronic ObstructiveCOPDExercise capacityLongitudinal analysisPhysical activity

Identifiers

PMID31959169
PMCPMC6972031

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.